Use of rituximab and irradiated donor-derived lymphocytes to control Epstein-Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation

J. P. McGuirk, S. Seropian, G. Howe, B. Smith, L. Stoddart, D. L. Cooper

Research output: Contribution to journal › Article › peer-review